Name | Number of supported studies | Average coverage | |
---|---|---|---|
GABAergic neuron | 4 studies | 37% ± 13% | |
glutamatergic neuron | 4 studies | 39% ± 13% | |
interneuron | 3 studies | 47% ± 18% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 31% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 98% | 5792.77 | 1421 / 1445 | 89% | 10.78 | 163 / 183 |
ovary | 98% | 8442.93 | 177 / 180 | 85% | 6.23 | 366 / 430 |
brain | 87% | 7007.85 | 2303 / 2642 | 75% | 7.40 | 527 / 705 |
prostate | 82% | 1439.47 | 202 / 245 | 73% | 3.49 | 364 / 502 |
intestine | 81% | 1993.51 | 781 / 966 | 73% | 4.41 | 384 / 527 |
thymus | 61% | 726.57 | 398 / 653 | 80% | 4.59 | 481 / 605 |
lung | 47% | 705.14 | 272 / 578 | 83% | 6.19 | 964 / 1155 |
stomach | 60% | 1815.48 | 214 / 359 | 68% | 4.21 | 195 / 286 |
uterus | 44% | 481.24 | 74 / 170 | 78% | 7.70 | 357 / 459 |
spleen | 100% | 19895.59 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 11.14 | 44 / 45 |
pancreas | 7% | 82.80 | 23 / 328 | 75% | 4.23 | 133 / 178 |
skin | 72% | 2278.59 | 1296 / 1809 | 8% | 0.38 | 39 / 472 |
adrenal gland | 60% | 753.25 | 155 / 258 | 15% | 0.80 | 35 / 230 |
bladder | 19% | 228.52 | 4 / 21 | 47% | 2.46 | 237 / 504 |
kidney | 39% | 437.38 | 35 / 89 | 9% | 0.35 | 82 / 901 |
breast | 13% | 138.00 | 59 / 459 | 35% | 1.57 | 386 / 1118 |
adipose | 13% | 142.62 | 152 / 1204 | 0% | 0 | 0 / 0 |
liver | 3% | 29.15 | 6 / 226 | 9% | 0.88 | 37 / 406 |
heart | 4% | 48.97 | 35 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 4% | 50.70 | 52 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 3% | 0.11 | 2 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0120009 | Biological process | intermembrane lipid transfer |
GO_0015914 | Biological process | phospholipid transport |
GO_0006661 | Biological process | phosphatidylinositol biosynthetic process |
GO_0042995 | Cellular component | cell projection |
GO_0044297 | Cellular component | cell body |
GO_0012505 | Cellular component | endomembrane system |
GO_0005829 | Cellular component | cytosol |
GO_0016020 | Cellular component | membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0008526 | Molecular function | phosphatidylinositol transfer activity |
GO_0004620 | Molecular function | phospholipase activity |
GO_0005509 | Molecular function | calcium ion binding |
GO_0005515 | Molecular function | protein binding |
GO_0008289 | Molecular function | lipid binding |
GO_0030971 | Molecular function | receptor tyrosine kinase binding |
Gene name | PITPNM3 |
Protein name | Membrane-associated phosphatidylinositol transfer protein 3 (Phosphatidylinositol transfer protein, membrane-associated 3) (PITPnm 3) (Pyk2 N-terminal domain-interacting receptor 1) (NIR-1) PITPNM family member 3 |
Synonyms | NIR1 |
Description | FUNCTION: Catalyzes the transfer of phosphatidylinositol and phosphatidylcholine between membranes (in vitro) (By similarity). Binds calcium ions. . |
Accessions | I3L1K1 ENST00000262483.13 [Q9BZ71-1] A1A5C9 ENST00000575201.2 ENST00000421306.7 [Q9BZ71-3] Q9BZ71 |